ABSTRACT: A member of the Fasciola hepatica saposinlike/NK-lysin protein family with lytic activity on human peripheral blood mononuclear cells and erythrocytes was recently described. The current study was designed to test the immunoprophylactic potential of this protein termed FhSAP-2 against infection with F. hepatica in rabbits. Two doses of 50 g of recombinant FhSAP-2 (rFhSAP-2) emulsified in TiterMax were injected subcutaneously on the dorsal surface of 4 rabbits at 2-wk intervals. Four weeks after the second immunization, the rabbits were infected orally with 25 F. hepatica metacercariae. Four non-immunized-infected rabbits were used as controls. An enzymelinked immunosorbent assay revealed high levels of antibodies to both rFhSAP-2 and F. hepatica excretory-secretory antigens by 2 wk after the first immunization, which were always significantly higher in immunized-infected rabbits than in control-infected rabbits. On the completion of the trial, vaccinated rabbits had 81.2% less flukes than controls. Moreover, F. hepatica egg counts in feces, as well as in bile collected from the gall bladders from vaccinated animals, were lower, 83.8 and 73%, respectively, compared with controls. The vaccinated rabbits also had significantly lower amounts of parasite antigen in stool and bile samples than controls. Last, evaluation of macroscopic liver lesions revealed that the rabbits vaccinated with rFhSAP-2 had milder lesions than the infected-control rabbits. These findings support the hypothesis that this novel rFhSAP-2 protein has immunoprophylactic potential against fascioliasis in rabbits including antifecundity and antipathology effects. This is the first report on experimental vaccination of rabbits against F. hepatica with a purified, defined, recombinant protein related to a member of the saposinlike protein family.
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Fascioliasis caused by infection with the trematode parasite Fasciola hepatica is a very widespread parasitic infection in temperate climate regions throughout the world. It is considered an important economic disease of sheep and cattle. The losses caused by this parasite have been estimated over 3 billion U.S. dollars annually (Spithill et al., 1999) . Moreover, human infections are common in endemic zones of Latin America such as the Altiplano of Bolivia (Hillyer et al., 1992; Bjorland et al., 1995; Esteban et al., 1997) . The control of fascioliasis in herbivores is, almost exclusively, carried out by the strategic application of anthelmintics. Although there are a great number of efficacious pharmaceuticals against adult stages, only triclabendazole is efficient both against adults in the biliary tract and immature flukes in the hepatic parenchyma (Boray et al., 1983) . However, because triclabendazole does not prevent reinfection, the herbivores in endemic areas must be continuously treated with the drug, and there is the problem of the development of drug-resistance strains (Overend and Bowen, 1995) . In the search for an alternative to control fascioliasis, the development of an efficient and commercially viable vaccine is necessary.
Recently, we reported the molecular cloning and expression of a lytic protein of 11.5 kDa termed recombinant FhSAP-2 (rFhSAP-2), which was defined as a member of the F. hepatica saposinlike/NK-lysin protein family (Espino and Hillyer, 2003) . This protein is highly reactive with sera from rabbits with F. hepatica for 2-14 wk, as well as with sera from humans with chronic fascioliasis, which suggests that rFh-SAP-2 is a strong immunogen. Interestingly, an anti-rFhSAP-2 rabbit antiserum revealed the presence of a major 11.5-kDa polypeptide in F. hepatica excretory secretory (FhES) antigens and a Schistosoma mansoni whole-worm extract, suggesting that FhSAP-2 is a Fasciola-Schistosoma cross-reactive antigen that may be released from cytoplasmic storage granules present within F. hepatica parasites. The current study was designed to determine the immunoprophylactic activities of rFh-SAP-2 to infection with F. hepatica in rabbits.
The rFhSAP-2 protein was purified by nickel-affinity chromatography as described previously (Espino and Hillyer, 2003) . Eight, 3-mo-old male New Zealand white rabbits (Harlan Sprague Dawley, Inc., Indianapolis, Indiana) were divided into 2 groups of 4 animals each. One group was immunized subcutaneously with 50 g of rFhSAP-2 emulsified in TiterMax Classic Adjuvant (Sigma Chemical Co., St. Louis, Missouri), and 2 wk later they received a second dose. The other group was immunized with phosphate-buffered saline (PBS) emulsified in TiterMax and used as control group. Four weeks after the second immunization, both groups were infected orally with 25 F. hepatica metacercariae (Baldwin Aquatics Inc., Monmouth, Oregon) and were necropsied 10 wk after infection. The rabbits were bled before immunization and then at 2-wk intervals for the collection of serum. Stool samples were collected from each rabbit 8 wk after infection and at necropsy 10 wk after infection. At this time, the bile content of the gall bladder was also collected. Stool and bile samples were examined by a quantitative sedimentation technique (Thienpont et al., 1986) . The egg count was expressed as eggs per gram of feces or egg per milliliter of bile, respectively. The hepatic damage due to invading parasite was evaluated subjectively by the observation of macroscopic alterations of the organ including the following: color change to grayish-white, increase in size and consistency, dilation and increased thickness of the bile ducts, the presence of mucopurulent deposits, and the formation of surface scars. The grade of lesions observed was summarized semiquantitatively using 4 stages symbolized by 1 through 4, plus symbols that expressed the intensity and extension of the alterations observed as follows: ϩ, mild; ϩϩ, moderate; ϩϩϩ, intense; ϩϩϩϩ, severe.
Two enzyme immunoassays were used in this study to evaluate the status of infection. An indirect enzyme-linked immunosorbent assay (ELISA) as described previously (Espino et al., 1987 (Espino et al., , 2001 served to measure the antibody response to FhES and FhSAP-2 antigens in the serum samples, and a capture enzyme immunoassay as described by Espino and Finlay (1994) served to determine the presence of parasite antigens in stool and bile samples. For antigen detection, stool eluates were prepared by suspending 1 g of fresh feces from individual specimens in 2 ml of PBS containing 0.05% Tween-20. They were stirred well with a wooden spatula and centrifuged at 900 g for 2 min after which the supernatant was collected and stored at Ϫ20 C until used. Two milliliters of the bile content of the gall bladder was centrifuged at 3,000 g for 5 min, and the supernatants were collected and stored at Ϫ20 C until used. The concentration of antigen (ng ml Ϫ1 of fecal suspensions or bile samples) was estimated by comparing the optical density (OD) values with a standard curve (r 2 ϭ 0.963), generated by spiking negative stool suspensions or bile samples with known quantities (from 5 to 1,000 ng) of FhES antigen.
Each ELISA and count of eggs was repeated 3 times, and the results were expressed as the mean OD 492 or mean egg count, respectively, for each determination. The weekly differences in OD 492 values between groups were analyzed using Student's t-test. The overall differences among groups were compared by analysis of variance (ANOVA) with 1 coefficient of variation. When global differences were detected in this analysis, we applied a post-ANOVA test using Fisher's protected least significant difference analysis. Results are reported as mean Ϯ SD. All analyses were considered significant at P Ͻ 0.05. The relationships among the numbers of adult flukes, the count of eggs, and the antigen concentration were studied by using Spearman's correlation rank test.
After necropsy, the livers of the vaccinated and control rabbits were carefully examined. No immature fluke was recovered from the liver parenchyma of immunized or control rabbits. All the control rabbits were infected as demonstrated by the finding of adult flukes in their FIGURE 1. ELISA absorbance profile of the reactivity of the FhES antigen (left graph) and the rFhSAP-2 protein (right graph) with the sera from control rabbits and rabbits immunized twice with rFhSAP-2 and challenged 4 wk later with Fasciola hepatica metacercariae. Rabbits immunized with adjuvant and challenged at 4 wk of the last immunization were used as controls. Standard error bars are shown. ·····. Cutoff value OD Ն 0.21. Arrow indicates the challenge infection time of rabbits. FIGURE 2. ES78 capture ELISA (ES78-ELISA) for the determination of Fasciola hepatica antigen concentration in stool and bile samples from rabbits with fascioliasis for 8 wk. Rabbits 1-4 were immunized twice with rFhSAP-2 and challenged 4 wk after the second immunization. Control rabbits (5-8) were immunized with adjuvant and challenged at 4 wk after the second immunization. Dashed lines (--) are cutoff value Ն 15 ng of protein antigen. Numbers above bars in parentheses indicate mean number of eggs per gram of feces or number of eggs per milliliter of bile.
bile ducts. The mean number of worms recovered in the control group was 4 Ϯ 0.71. Significant liver damage was seen in the control group, ranging in scoring from severe to intense lesions. The number of flukes recovered from the livers of the immunized animals was significantly lower than that from the control group. No fluke was recovered from 1 of the vaccinated rabbits, although hepatic lesions were observed, suggesting infection. The mean number of flukes recovered from the immunized rabbits was 0.75 Ϯ 0.43. Reduction in mean worm burdens was significant (P Ͻ 0.05), i.e., 81.2%. The overall length of flukes recovered from control group was also significantly longer than that of flukes recovered from the immunized group that had a 60.6% reduction in length (Table I) . Moreover, the immunized rabbits had milder liver lesions at the right lower portion of the liver (Table I) . A significant reduction of 83.8% in the number of eggs per gram of feces was observed in the immunized animals as compared with the control group. Moreover, the eggs per gram of feces per fluke parameter also showed an important and significant reduction of 53.8% in the vaccinated versus the control group. The number of eggs in the bile was also significantly lower in the immunized group (73%) than in the control group. However, this reduction was not significant when it was expressed as number of eggs per milliliter of bile per fluke (Table I) .
Rabbits immunized with rFhSAP-2 developed circulating antibodies to both the rFhSAP-2 protein and to FhES by 2 wk after a single immunization, peaking 4 wk after the second immunization (Fig. 1) . After challenge, no further increase in antibodies to rFhSAP-2 was observed in the immunized rabbits. In contrast, control rabbits were reactive to rFhSAP-2 by 2 wk of infection, reaching maximum absorbance values 4 wk after infection.
The fecal suspensions from the control rabbits collected 8 wk after challenge had detectable antigens (Ն15 ng ml Ϫ1 ) in the range of 450-655 ng, with a mean value of 523 Ϯ 79.7. The antigen concentration in stool suspensions from vaccinated animals was significantly lower than that in controls (Fig. 2) . One vaccinated animal, from which no fluke was recovered, was consistently negative in this assay. The antigen concentration in stool suspensions of the other 3 vaccinated rabbits ranged from 15 to 35 ng (x 22.5 Ϯ 11.3). The stool samples collected at necropsy (10 wk after infection) showed a similar antigen concentration to that observed at 8 wk. This indicates that parasite antigen concentration reaches maximum levels shortly before patency. When bile fluid samples were tested, antigen concentrations from 755 to 978 ng (886 Ϯ 81.8) and from 19 to 42 ng (27 Ϯ 13.9) were detected for the control and immunized group, respectively.
The concentration of antigen in stools as well as in bile sample correlated significantly with the number of eggs or number of parasites recovered postmortem. The smallest number of adult flukes in the liver of vaccinated animals was 1, and their antigens were detected by the assay. Antigen was not detected in either stool or bile samples from the rabbit that no had fluke in its liver.
Until now, the major groups of antigens that have demonstrated certain protective capacity against fascioliasis are the 26/28-kDa glutathione S-transferases (enzymes with a detoxifying activity [Sexton et al., 1990; Morrison et al., 1996] ), the extracellular proteases such as the cathepsin-L-proteinases and leucine aminopeptidase (Wijffels et al., 1994; Dalton et al., 1996; Piacenza et al., 1999) , and proteins that transport fatty acids (Hillyer et al., 1987; Rodriguez Perez et al., 1992; Muro et al., 1997) . This is the first report in which a member of the F. hepatica saposinlike protein is tested for its immunoprophylactic potential against fascioliasis in rabbits. Our results indicate that a significant reduction in fluke burden, decreased hepatic damage, and a significant reduction in egg output occurred after vaccinating rabbits with the rFhSAP-2 protein. The differences in parasite burden between the immunized and control group are consistent with the significant difference observed in the parasite antigen concentration detected in stools and bile samples from both groups at necropsy. The capture assay used to detect the parasite antigens in stool or bile fluid samples from rabbits uses the monoclonal antibody ES78 (mouse IgG 2a ), which is highly specific and only recognizes excretory secretory (ES) antigens of F. hepatica (Espino et al., 1997) . Previous studies have demonstrated that the antigenic epitope recognized by ES78 is present on ES antigens derived from both immature and mature flukes (Espino and Finlay, 1994) . Moreover, the concentration of parasite antigens in body fluids is directly proportional to the amount of parasite in the liver and correlates with egg output levels (Espino et al., 1998; Dumenigo et al., 2000) .
The reduction in size of the flukes in the immunized animals must also be interpreted as a sign of protection because it implies a deficiency in their normal physical development (Estuningsih et al., 1977) . The deficiencies in the physical development, translated to a decrease in the mass and corporal dimensions of the worms, are accompanied, with great frequency, by deficiencies in biological development. This is reflected in the delay in maturation and in a decrease in the number, or absence, of eggs in the uterus and consequently a reduction in the number of eggs eliminated through the bile and feces. This seems to indicate that the recombinant protein termed rFhSAP-2 induces protective (worm burden reductions), antifecundity (reduction of eggs), and antipathology (less liver lesions) effects. Remarkably, nearly identical findings were noted in rabbits against fascioliasis with another vaccine candidate described from our laboratory, a native 12-kDa and recombinant 15-kDa fatty acid-binding protein (FABP; Rodriguez Perez et al., 1992; Muro et al., 1997; Casanueva et al., 2001) . Moreover, worm size and fecal egg counts were significantly diminished in sheep vaccinated with either the native or recombinant F. hepatica FABP, also suggesting an antifecundity effect (Ramajo et al., 2001) . This is the second immunoprotective antigen against fascioliasis reported by our laboratory. Like the first, rFhSAP-2 is a strong immunogen because antibodies appear by 2 wk of F. hepatica infection (Espino and Hillyer, 2003) . The first one we described is a F. hepatica FABP that also induces antibodies by 2 wk of infection in mice, rabbits, and calves with fascioliasis. It also cross-reacts with serum from mice by 6 wk of infection with S. mansoni (Hillyer, Soler de Galanes et al., 1988) and crossprotects against murine schistosomiasis mansoni (Hillyer, 1985; Hillyer, Garcia-Rosa et al., 1988; Hillyer et al., 1990) . Its recombinant protein has also been described (Rodriguez Perez et al., 1992) . The converse has also been demonstrated. Thus, an S. mansoni recombinant FABP has been described (Moser et al., 1991) and shown to protect against murine schistosomiasis mansoni and crossprotects against murine and ovine fascioliasis (Tendler et al., 1996; Almeida et al., 2003) .
Because the rFhSAP-2 protein is another Fasciola-Schistosoma cross-reactive antigen (Espino and Hillyer, 2003) , its protection-inducing activity against S. mansoni clearly needs to be determined. This study was supported by the NIH research grant T37 TW 00096 funded by the Fogarty International Center. We thank D. Torres for excellent technical assistance. Measures of parasitemia by intraerythrocytic hematozoan parasites are normally expressed as the number of infected erythrocytes per n erythrocytes and are notoriously tedious and time consuming to measure. We describe a protocol for generating rapid counts of nucleated erythrocytes from digital micrographs of thin blood smears that can be used to estimate intensity of hematozoan infections in nonmammalian vertebrate hosts. This method takes advantage of the bold contrast and relatively uniform size and morphology of erythrocyte nuclei on Giemsa-stained blood smears and uses ImageJ, a java-based image analysis program developed at the U.S. National Institutes of Health and available on the internet, to recognize and count these nuclei. This technique makes feasible rapid and accurate counts of total erythrocytes in large numbers of microscope fields, which can be used in the calculation of peripheral parasitemias in low-intensity infections.
LITERATURE CITED
Field and laboratory studies of intraerythrocytic hematozoan parasites have traditionally relied on methanol-fixed, thin smears of peripheral blood for diagnostics, estimations of prevalence, and measures of intensity of infection. Whereas polymerase chain reaction and serological techniques are playing an increasingly important role in diagnostics and estimations of prevalence because of their greater sensitivity, measures of intensity of infection (parasitemia) still largely depend on manual counts of erythrocytes on stained blood smears. Though tedious and time consuming to produce, these measures provide important information about the dynamic interaction between host immune responses and parasite reproductive rates (McKenzie and Bossert, 1997) . This information is essential for clinical studies of the temporal dynamics and pathogenicity of infection in experimentally infected hosts (Atkinson et al., 1987 (Atkinson et al., , 2000 and for ecological studies that seek to identify the impacts of hematozoan infections on host fitness (Merino et al., 2000) .
In very intense infections, accurate estimates of parasitemia can be made from as few as 2,000 erythrocytes (Godfrey et al., 1987) . However, low-intensity infections of some hematozoa may have fewer than 1 parasite per 50,000 erythrocytes (Jarvi et al., 2002) , making it impractical to count erythrocytes and estimate parasitemias when numbers of samples are large. Most authors have reported estimates of parasite intensity by extrapolating from partial counts or by examining smears for fixed time intervals, but both these approaches have been shown to be inaccurate and unreproducible (Godfrey et al., 1987; Fedynich et al., 1995) . Here, we describe a method for making automated counts of nucleated erythrocytes by digital image analysis. The bold contrast and unique morphology of Giemsa-stained nuclei make them optimal targets for automated object recognition and counting. This technique makes feasible rapid and accurate counts of total erythrocytes in large numbers of microscope fields, which can be used in the calculation of peripheral parasitemias in low-intensity infections.
Blood samples were drawn from the jugular veins of 6 species of birds involved in both field and laboratory studies of Plasmodium relictum (Atkinson et al., 2000) (Table I) . Thin blood smears were prepared on glass microscope slides, fixed with absolute methanol, and stained with 6% (v/v) Giemsa diluted in 0.02 M phosphate buffer, pH 7.0, for 1 hr. For all smears, a random starting place was selected near the feathered, leading edge of the blood film with a random number table. One hundred adjacent fields were examined and photographed on each of 10 slides with a ϫ40 objective, ϫ1.25 image multiplier, and a ϫ10 eyepiece by moving the stage 1 field at a time perpendicular to the long axis of the slide, over 1 field and then back down. Images were collected with an Olympus DP11 digital camera set to a resolution of 1,150 ϫ 800 pixels with automatic metering, exposure, and white balance.
Images were opened using ImageJ (http://rsb.info.nih.gov/ij/), a public domain, java-based program developed at the U.S. National Institutes of Health and available on the internet at http://rsb.info.nih.gov/ nih-image/ (Rasband, 2002) . Each image was converted to an 8-bit (grayscale) format and subjected to automatic thresholding, which converts grayscale images into binary (black and white) mode using a cutoff value established by algorithms (Ridler and Calvard, 1978) .
The ''analyze particles'' command in Imagej identifies and counts thresholded particles (in our case, islands of black pixels) meeting userspecified criteria, e.g., minimum and maximum size. Smears containing many overlapping erythrocytic nuclei cannot be counted by this method because ''connected'' nuclei will threshold to a single particle. We obtained particle analysis parameters by adjusting values and observing results on an image taken from a house sparrow (Passer domesticus) blood smear. A particle size of minimum 200 with maximum 800 pixels most effectively encompassed erythrocyte nuclei and excluded other blood cells and debris. These values were used for all blood smears in the study, but may not be appropriate for all hosts or image-capture settings. Nuclei contacting the edge of the image (representing cells that FIGURE 1. Close-up view of a ϫ500 field from a blood smear from a Hawaiian Amakihi (Hemignathus virens). The original JPEG microscope image was subjected to automatic thresholding and particle analysis and then saved as a single image in TIFF format. The TIFF image was then overlaid on the original JPEG image in Adobe Photoshop 6.0 and the white background between particles was selected and deleted using the wand tool, leaving counted particles superimposed on the original image. Elliptical particles with cytoplasmic auras were identified as correctly counted nuclei. A. Incorrectly counted debris. B. Correctly dismissed debris. C. Correctly counted nuclei. D. Incorrectly dismissed nuclei. may contain parasites beyond the reading frame) were excluded from analysis.
Manual counts of erythrocytes were made as follows. After particle analysis, particle outlines were saved in TIFF format. TIFF images were overlaid on original JPEG images of microscope fields in Adobe Photoshop 6.0 (Adobe Sytems, Inc.). The white background between particles was selected and deleted using the wand tool, leaving counted particles superimposed on the original image (Fig. 1 ). Elliptical particles with cytoplasmic auras were identified as correctly counted nuclei; nonnucleic particles and nuclei missed by particle analysis were noted for each image.
Manual and automated counting of erythrocytes yielded very similar results for 423,314 erythrocytes in 1,000 fields from 10 blood smears (Table I) . In most fields, particle analysis missed few erythrocytes or counted few pieces of debris, leukocytes, or lysed nuclei (Fig. 1) . Overall, automated particle analysis misidentified an average of 3.22 objects for every 1,000 erythrocytes examined. The best results were obtained from clean, well-stained smears containing few lysed cells. Therefore, we stress the importance of preparing clean smears, fixing them immediately, and staining them within a few weeks. The quality of photomicroscopy was also important, with sharply focused, well-illuminated, higher-contrast images producing more accurate erythrocyte counts. Godfrey et al. (1987) reported that quantifying parasitemia from 20,000 erythrocytes takes approximately 5 hr. We required the same amount of time to manually count erythrocytes in 100 microscope fields. Using automatic thresholding and particle analysis, we were able to reduce this time to 30 min. We consider this a successful demonstration of the utility of particle analysis but caution that irregular slides may produce aberrant results. By verifying that most particles are nuclear sized and nuclear shaped or creating overlays on original images as described above, investigators can retain confidence in the legitimacy of their counts.
Automated cell counting relies on the differentiation of nuclei from cytoplasm, thus any nucleophilic stain, e.g., Diff-Quik, will yield countable smears. Although we tested this protocol only on birds, we expect that by adjusting threshold limits and particle size boundaries, Imagej or other image analysis programs can be adapted to count cells in clean smears from any host with nucleated erythrocytes.
The method presented here cannot estimate parasitemias but substantially accelerates the most time-consuming stage of their acquisition (the counting of erythrocytes). In cases of low-intensity infections, handcounting parasites during image capture takes only a few minutes. Automatic thresholding is less successful at counting cells in smears with higher parasitemias; such smears typically contain both erythrocytes that are highly variable in size and many large parasites, which may be counted as erythrocyte nuclei. As mentioned earlier, high-intensity parasitemias can be rapidly estimated by manual counting of comparatively few cells.
A number of protocols already exist for automated estimation of parasitemia in mammals (e.g., Diggs and Osler, 1969) . Impressively, 1 group has developed an automated method of identifying, counting, and classifying malaria parasites in humans (Di Ruberto et al., 2002) . In studies of wildlife disease, the occurrence of multiple, morphologically varied parasites pose considerable challenges to automated parasite recognition. Nevertheless, it may be possible to further expedite estimates of parasitemia by developing a technique for automated recognition of blood parasites themselves.
Supported in part by National Institutes of Health grant 1-R01-TW-1581-1 and National Science Foundation grant 0083944. Andrea Clewley assisted with image capture. Michael Samuel, Dennis LaPointe, and 2 anonymous reviewers provided helpful comments during the preparation of this manuscript. Equine protozoal myeloencephalitis is a neurologic disease in horses from the Americas and is usually caused by infection with the apicomplexan parasite Sarcocystis neurona . It is the most important protozoan disease of horses in North America (reviewed by Dubey, Lindsay, Saville et al., 2001 ). The Virginia opossum Didelphis virginiana is the only known definitive host in North America (Dubey and Lindsay, 1998) , whereas Didelphis albiventris is a host in South America (Dubey, Lindsay, Kerber et al., 2001 ). Nine-banded armadillos (Dasypus novemcinctus), raccoons (Procyon lotor), and sea otters (Enhydra lutris) are natural intermediate hosts Dubey, Rosypal et al., 2001; Dubey, Saville et al., 2001; Tanhauser et al., 2001) . Domestic cats (Felis domesticus), striped skunks (Mephitis mephitis), and raccoons are known experimental intermediate hosts (Dubey et al., 2000; Cheadle, Yowell et al., 2001; Dubey, Saville et al., 2001) . Dubey, Saville et al. (2001) reported clinical encephalitis in experimentally infected raccoons. Stanek et al. (2002) described the life cycle of S. neurona in experimentally infected raccoons.
This study was conducted to determine the serological prevalence of antibodies to S. neurona in a common intermediate host, the raccoon. The direct S. neurona agglutination test (SAT) described by Lindsay and Dubey (2001) was used.
Raccoons originated in various locations in Fairfax County, Virginia, a suburban-urban area outside Washington, D.C. Raccoons used for this study were livetrapped as part of a larger study on rabies in Fairfax County. Blood samples were collected from all trapped raccoons. Raccoons were released immediately after sampling was completed. The serum was collected, placed in a tube, and frozen at Ϫ70 C. Frozen sera were sent to the Center for Molecular Medicine and Infectious Diseases, Department of Biomedical Sciences and Pathobiology, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Tech, Blacksburg, Virginia for agglutination testing. Samples from 137, 120, and 212 raccoons from 2000, 2001, and 2002, respectively, were examined (total ϭ 469 for 3 yr). The SAT was used to test sera at dilutions of 1:50. The SAT has previously been validated using sera from experimentally infected raccoons (Dubey, Saville et al., 2001; Lindsay et al., 2001; Stanek et al., 2002) .
The This study is the largest conducted to date on the prevalence of S. neurona antibodies in raccoons. Mitchell et al. (2002) examined sera from 12 raccoons from Connecticut and found that all 12 were positive in the SAT. Lindsay et al. (2001) demonstrated that sera from 33% of raccoons (n ϭ 24) from Florida, 72% of raccoons (n ϭ 25) from New Jersey, 52% of raccoons (n ϭ 25) from Pennsylvania, and 96% of raccoons (n ϭ 25) from Massachusetts were positive in the SAT.
Clinical Sarcocystis sp.-associated encephalitis and myocarditis are common in raccoons (Stoffregen and Dubey, 1991; Thulin et al., 1992; Dubey, Hamir et al., 1990; Hamir and Dubey, 2001 ). These animals are often coinfected with canine distemper (Stoffregen and Dubey, 1992; Thulin et al., 1992) . Experimental infection of raccoons with S. neurona is also potentially pathogenic for raccoons (Dubey, Saville et al., 2001; Stanek et al., 2002) . Sarcocystis kirkpatricki is the only other named species of Sarcocystis infecting the muscles of raccoons (Snyder et al., 1990) . Kirkpatrick et al. (1987) found sarcocysts in 26 (50%) of 52 raccoons from Ohio, Pennsylvania, Florida, and Maryland. Snyder et al. (1990) found S. kirkpatricki sarcocysts in 66 of 100 raccoons examined from Illinois. Demonstration of sarcocysts in tissues is not as accurate as acid-pepsin digestion of tissues or serological methods, and this method usually underestimates prevalence. The life cycle of S. kirkpatricki is not known. Molecular studies are needed to determine the taxonomic relationship between S. neurona and S. kirkpatricki.
Parvicapsula minibicornis in Anadromous Sockeye (Oncorhynchus nerka) and Coho (Oncorhynchus kisutch) Salmon From Tributaries of the Columbia River
Simon Jones, Gina Prosperi-Porta, Sheila Dawe, Kimberley Taylor, and Benjamin Goh, Department of Fisheries and Oceans, Pacific Biological Station, 3190 Hammond Bay Road, Nanaimo, British Columbia, V9T 6N7 Canada. e-mail: joness@pac.dfo-mpo.gc.ca ABSTRACT: The myxosporean parasite Parvicapsula minibicornis is described from adult sockeye and coho salmon during spawning migrations in tributaries of the Columbia River in Canada and the United States. These observations extend the known distribution of this parasite from the Fraser River drainage basin. The parasite was identified in Columbia River salmonids using polymerase chain reaction (PCR) and by in situ hybridization, but unlike in Fraser River salmon, it was not observed in conventional histological preparations of the kidney. Prevalence of the parasite determined by PCR was higher in spawning sockeye from the Fraser River than in those from the Okanagan River. Our ability to explain the relatively low prevalence and absence of clinical Tissues fixed in Davidson's solution were dehydrated in an isopropanol gradient, cleared with xylene, and embedded in paraffin. Sections (5 m) were mounted on glass slides and exposed to modified Pappenheim stain (Humason, 1972) . The presence of trophozoite or sporoblast myxozoan stages within glomeruli was considered as histological evidence for infection. Similarly, the severity of infection was calculated based on the number of glomeruli containing developing parasites, of 25 glomeruli randomly examined from each fish.
Approximately 35 mg of the ethanol-fixed kidney was placed in separate 1.5-ml capped tubes for DNA extraction. The remainder of the ethanol-fixed kidney was further dehydrated and embedded in paraffin as described above. Sections (5 m) were mounted on aminoalkylsilane-treated glass slides for in situ hybridization (ISH).
DNA was extracted from ethanol-fixed tissues using DNeasy kits (Qiagen, Mississauga, Ontario, Canada) following the manufacturer's protocols and adjusted to 10 g/ml in deionized distilled water. Polymerase chain reaction (PCR) was used to amplify a 1,019-bp segment of P. minibicornis 18S ribosomal DNA (rDNA) from the extracted template DNA obtained from infected kidney as previously described (Kent et al., 2000; St-Hilaire et al., 2002) . Amplification products were visualized by UV transillumination in 1.5% agarose gels after electrophoresis and staining with ethidium bromide. Prevalence of P. minibicornis was compared among samples by analysis of chi-square contingency tables.
A second PCR protocol was designed to amplify a 359-bp segment (nucleotides 828-1,186) of P. minibicornis 18S rDNA from which a digoxigenin (DIG)-labeled probe was prepared. The 50-l reaction volume contained 1 M each of primers Parvish2f (5Ј-GAA CGA ATT GAA TAG CGT AGG TG-3Ј) and Parvi2r, 1.5 mM MgCl 2 , 0.2 mM deoxynucleoside triphosphates, 0.05 U/l Platinum Taq (Invitrogen, Burlington, Ontario, Canada), and 1 ng/l of infected tissue DNA. Parvi2r was the same primer used in the initial PCR and has been described earlier (Kent et al., 2000) . The reaction profile was similar to that previously described, but using an annealing temperature of 55 C. The resulting product was purified as described above, and 100 ng was used as template DNA in a conventional (1 M each of primers Parvish2f and Parvi2r) PCR using the DIG Probe Synthesis kit (Roche, Laval, Quebec, Canada) following the manufacturer's protocols. Products obtained from several reactions were pooled, purified as above, quantified by spectrophotometry, and stored at Ϫ20 C.
The method reported earlier for detection of Kudoa thyrsites by ISH (Jones, Goh et al., 2003) was followed. After development of the formazan stain, tissue sections were examined using a compound microscope, and the number of staining parasite stages observed in 100 microscopic fields (ϫ1,000 magnification) was counted. As controls, the DIG-labeled P. minibicornis probe was incubated with uninfected sockeye kidney, Atlantic salmon (Salmo salar) muscle infected with K. thyrsites, and coho salmon (O. kisutch) kidney infected with extrasporogonic stages of a Sphaerospora-like myxozoan. The control tissues were also fixed in ethanol. In addition, sockeye salmon kidney infected with P. minibicornis was incubated with an irrelevant DIG-labeled probe. Micrographs were obtained using a Nikon Coolpix 995 digital imaging system mounted on a Leitz Dialux 22 compound microscope.
A 1,019-bp fragment of P. minibicornis 18S ribosomal RNA gene was amplified from all 46 kidney samples from spawned Horsefly River sockeye and from all 40 Weaver Creek sockeye in 2002. Compared with the Horsefly River population, significantly fewer Okanagan River sockeye were positive in 2001 (8 of 40; 2 ϭ 58.6; P Ͻ 0.001) and in 2002 (27 of 40; 2 ϭ 17.6; P Ͻ 0.001). Parvicapsula minibicornis DNA was detected in 3 of 4 sockeye from Redfish Lake, Idaho; in all 4 sockeye from the Deschutes River, Oregon; in all 8 coho salmon from the Wenatchee River; and in 5 of 11 coho from the Methow River.
Evidence of P. minibicornis was observed in stained histological preparations from all 40 Weaver Creek sockeye and all 42 Adams River sockeye collected in 2002. Mean severities at these sites were 24.8 and 20.7, respectively. The parasite was not detected in the glomeruli of any of 80 sockeye collected from the Okanagan River, or in 4 from the Deschutes River, or 3 from Redfish Lake. Similarly, no histological evidence of P. minibicornis was observed in any of 19 coho salmon from the Wenatchee and Methow rivers.
ISH staining reactions were detected readily in spawned sockeye from the Fraser River ( Fig. 1 ; Table I ) but infrequently in PCR-positive sockeye from the Okanagan and Deschutes rivers ( Fig. 2 ; Table I ). No ISH reaction was observed in coho salmon kidney infected with a Sphaerospora sp.-like organism or in Atlantic salmon skeletal muscle infected with K. thyrsites after incubation with the P. minibicornis probe.
The finding of P. minibicornis DNA in sockeye and coho salmon from several tributaries of the Columbia River increased the known distribution of this parasite and confirmed its lack of strict host specificity. Although detecting the parasite in anadromous salmon in a drainage system adjacent to its original known distribution may not have been surprising, it was interesting to note that the prevalence and severity of infections in Columbia salmon were dissimilar to those in Fraser sockeye. Parvicapsula minibicornis is readily detectable by PCR in virtually all postspawn Fraser drainage sockeye (St-Hilaire et al., 2002; Jones, Prosperi-Porta et al., 2003) . This widespread distribution within Fraser drainage sockeye was confirmed in the present study. Compared with its prevalence in Fraser sockeye, the parasite was detected in a significantly smaller proportion of Okanagan River sockeye in 2001 and 2002. Although the parasite was also shown to occur in Columbia sockeye from Idaho and Oregon, the relatively small sample sizes precluded a confident estimation of prevalence. Relatively severe glomerular infections were observed in most postspawn Fraser River sockeye, confirming earlier studies (Raverty et al., 2000; St-Hilaire et al., 2002; Jones, Prosperi-Porta et al., 2003) . In contrast, no evidence of infection was observed in stained histological sections from any sockeye collected at or near spawning grounds in tributaries of the Columbia River, including 42 sockeye in which infections were detected by PCR. Similarly, St-Hilaire et al. (2002) found no histological evidence of infection in spawned sockeye collected from the Okanagan River in 1999 and 2000. The failure to detect P. minibicornis in stained histological preparations from PCR-positive Columbia coho was consistent with our observations in Columbia sockeye. In an earlier study of Fraser coho (Jones, Prosperi-Porta et al., 2003) , P. minibicornis was detected by PCR in all 30 salmon and by traditional histology in 20 of these, suggesting that the inability to infect the glomerulus is a feature of the parasite in the Columbia River drainage.
The ability to explain a relatively low prevalence and absence of clinical P. minibicornis infections in Columbia salmon is hampered by our poor understanding of the life cycle of this parasite, particularly the identity and distribution of the putative intermediate host. Epidemiological observations of migrating Fraser sockeye indicate that the parasite is acquired as the fish reenter the estuary during the spawning migration (St-Hilaire et al., 2002) , and this is supported by caged sentinel studies (S. Jones, pers. obs.) . The prevalence and severity of infections increase during migration in the Fraser River, and infections are detected by PCR before they are detected by histological examination (Jones, Prosperi-Porta et al., 2003) . Light infections in Columbia FIGURES 1, 2. Parvicapsula minibicornis in sockeye salmon kidney after hybridization with a double-stranded DIG-labeled oligonucleotide probe. Hybridized probed is visualized using an anti-DIG monoclonal antibody labeled with alkaline phosphatase and staining with bromochloroindolyl phosphate (BCIP) and nitroblue tetrazolium. 1. Salmon from Gluskie Creek (Fraser River drainage), British Columbia. 2. Salmon from Deschutes River (Columbia River drainage), Oregon. Bars ϭ 30 m. Renal tubule (t) and glomerulus (g) containing formazan-stained parasites (p). salmon may therefore be caused by transmission of infection occurring further up-river than occurs in the Fraser River, providing less time for parasite development before salmon reach the spawning ground. Further work is required to identify the site of P. minibicornis transmission in the Columbia River. Two additional factors may also have contributed to these unusual patterns of infection. Innate resistance among Columbia salmon, perhaps the result of selection during historic association with the parasite (Jones, 2001) , may have reduced the severity of infection. Increased resistance to another myxozoan, Ceratomyxa shasta, has been reported among salmon populations occurring in streams in which the parasite is enzootic (Bartholomew, 1998) . Finally, strains of P. minibicornis occurring in the Columbia River may be constitutively less virulent than those from the Fraser River. Analysis of partial 18S rDNA sequences (data not shown) did not provide support for drainage basin-specific genotypes. However, until less-conserved sequences are examined, including those associated with parasite virulence factors, the possibility of drainage-associated virulence characteristics cannot be ruled out. A DIG-labeled DNA probe used by ISH specifically demonstrated P. minibicornis in the glomeruli, renal tubules, and, occasionally, the interstitium of Fraser sockeye. The probe confirmed that infections in Columbia sockeye were of low intensity and not associated with glomeruli. Parasite stages observed by ISH appeared to be extrasporogonic, and mature spores were not observed in Fraser or Columbia sockeye. Previous authors have reported that extrasporogonic stages of myxozoan and haplosporidian are more readily detected by ISH compared with mature spores (Stokes and Burreson, 1995; Frasca et al., 1999) . Ethanol fixation, adopted for field-based collections, may have reduced the resolution of fine details in ISH preparations. However, ethanol fixation minimizes the loss of ISH signal strength that is associated with prolonged storage in Davidson's solution or neutral buffered formalin (Jones, Goh et al., 2003) . The specificity of the probe was suggested by its failure to hybridize with K. thyrsites and a Sphaerospora sp.-like organism. Furthermore, BLAST analysis (Altschul et al., 1997) showed that at most 186 bp of the 359-bp probe shared 95% identity with the 100 most similar sequences available in GenBank. No identity with these sequences was evident among the remaining 173 bp. The DIGlabeled probe, by specifically recognizing morphologically indistinct extrasporogonic stages of P. minibicornis, will provide a useful tool in understanding the early development of this parasite in its vertebrate and possible invertebrate hosts.
An association has been observed between the pathological kidney lesions caused by severe P. minibicornis infections and elevated prespawning mortality among some late run-timing groups of Fraser River sockeye (Raverty et al., 2000; St-Hilaire et al., 2002) . Pathological changes of the kidney associated with P. minibicornis infections were not observed in Columbia drainage sockeye in the present study. Indeed, these infections were only recognized through the use of sensitive techniques that detected parasite genomic DNA. Until the factors that regulate the virulence of this organism are better understood, the stability of the apparently benign Columbia River form remains unknown.
We thank Dr. Keith Johnson, Idaho Fish and Game, Dr. Sonia Mumford, Olympia Fish Health Center, USFWS, and Dr. Mark Engelking, Oregon Department of Fish and Wildlife, for providing salmon tissues. We also thank Garth Traxler and Jon Richard, Fisheries and Oceans Canada, for providing sockeye samples. This study was funded by Fisheries and Oceans Canada and by the Pacific Salmon Foundation, Vancouver, British Columbia. ABSTRACT: This study was undertaken to observe the effects of hydrogen peroxide on Cryptosporidium parvum oocysts with respect to protease activity in comparison to known protease inhibitors. In assessing the possible mechanisms of action of hydrogen peroxide, treatment effectiveness was analyzed using 3 assays and the potential roles of proteases and cations were considered. Treatment of C. parvum oocysts with hydrogen peroxide inhibited protease activity up to 50% compared with untreated controls. Treatment of oocysts with chemicals that affect sulfhydryls, including N-ethylmaleimide and dithiolthreitol, inhibited protease activity by Ͼ90%. Treatment of oocysts with these chemicals, along with the protease inhibitors, phenylmethylsulfonyl fluoride (PMSF), ethylenediamine-tetraacetic acid, and cystatin, inhibited protease activity as well as in vitro excystation and infection in a cell culture assay. Several mechanisms may result in the successful inhibition of infection and excystation by hydrogen peroxide treatment, including: oxidation of oocyst wall proteins or lipids, chelating of cations necessary for infection, or hydroxyl radical-induced DNA damage to sporozoites, or both.
Cryptosporidium parvum is an intestinal apicomplexan parasite, which can cause severe illness in immunocompetent individuals (Tzipori, 1988 ) and life-threatening disease in immunocompromised individuals (Current and Garcia, 1991) and malnourished children (Griffiths et al., 1994) . Outbreaks of cryptosporidiosis result from water-and food-borne transmission of the small (4-5 m), environmentally resistant oocyst stage (Fayer et al., 2000) . Fecal-borne C. parvum oocysts are infectious immediately on passage from the body. When ingested by a susceptible person or animal, oocysts pass to the intestine where the sporozoites that are held within the oocyst wall excyst, enter enterocytes, and generate a predetermined series of life cycle stages. Excystation (release of the sporozoites from the oocyst) may be mediated by a combination of internal and external effects that have not been thoroughly described. Cryptosporidium parvum excystation has been observed in vitro by incubation at 37 C; it is enhanced by preincubation in a low-pH suspension medium and by addition of trypsin and bile salts to the suspension medium (Fayer and Leek, 1984; Kato et al., 2001) .
It has been proposed that specific proteases are involved in the excystation process and at least 1 step of the parasite invasion-infection process may be mediated by protease activity (Forney et al., 1996a (Forney et al., , 1996b . These protease-mediated or protease-dependent mechanisms have been studied more extensively in related apicomplexan parasites, including Plasmodium knowlesi, Plasmodium falciparum, Eimeria tenella, and Eimeria vermiformis (Dluzewski et al., 1986; Adams and Bushell, 1988; Fuller and McDougald, 1990; Que et al., 2002) . Protease-mediated events are believed to include host cell attachment (Adams and Bushell, 1988; Arroyo and Aldrete, 1989) , host membrane penetration (Hadley et al., 1983; Fuller and McDougald, 1990) , host protein degradation used for parasitic growth (Chappell and Dresden, 1986) , tissue migration (Moda et al., 1988; McKerrow et al., 1990; Moda and Doenhoff, 1994a; Morris and Sakanari, 1995; Yenbuter and Scott, 1995) , parasite development (Richer et al., 1993) , and mechanisms used to fight and evade the host immune system (Maizels et al., 1993; Pupkis et al., 1986; Moda and Doenhoff, 1994b) . Proteases, classified by the active group, are divided into 3 types: cysteine, serine, and metalloproteases. Because serine and cysteine proteinases increase in concentration during incubation at 37 C before excystation, they are thought to function in excystation of C. parvum oocysts and cleavage of oocyst wall proteins (Forney et al., 1996a) . Because the invasion process has been shown to be both pH-and metallodependent (Hamer et al., 1994) , proteases may be involved in this process also.
Although C. parvum oocysts are resistant to disinfection with concentrations of chlorine that readily render bacteria and viruses nonviable, other oxidizing agents, including ozone and hydrogen peroxide, more readily inhibit viability (Vassal et al., 1998; Rennecker et al., 2001) . Treatment of C. parvum oocysts with a low concentration of hydrogen peroxide, i.e., 0.03%, inhibited excystation (Kniel et al., 2003) . The amino acid cysteine is highly reactive and susceptible to oxidation. Cysteine-dependent enzymes are rendered inactive by loss of their free sulfhydryl group (reduced form), making cysteine proteases potential targets for chemotherapeutic attack. Hydrogen peroxide readily oxidizes sulfhydryl groups and could inhibit C. parvum excystation by affecting cysteine proteases previously identified as involved in excystation (Forney et al., 1996a) .
The purpose of this study was to better understand the possible modes of action of hydrogen peroxide, including the action in relation to protease activity and that compared with known chemical inhibitors. The protease activity of hydrogen peroxide at concentrations known to effect oocyst development was compared with that of untreated oocysts along with protease-inhibiting chemicals. The following 3 assays were used for this analysis, i.e., an HCT-8 cell culture infectivity assay, an in vitro excystation assay, and an in vitro proteolytic activity assay. Cryptosporidium parvum oocysts (Beltsville isolate) were obtained from infected dairy calves and processed at the Environmental Microbial Safety Laboratory, United States Department of Agriculture, Beltsville, Maryland . Oocysts were purified from fecal material as described previously (Kilani and Sekla, 1987) and quantified with the aid of a hemacytometer. Cryptosporidium parvum oocysts (5 ϫ 10 5 per treatment) were treated with 0.525% sodium hypochlorite at 4 C for less than 5 min and washed twice with Hanks Balanced Salt Solution (HBSS; Mediatech, Cellgro, Herndon, Virginia). Oocysts were then treated with protease inhibitors or related chemicals at specified concentrations for 30 min at 22 C or with specified concentrations of hydrogen peroxide in water for 2 hr at 4 C. Oocysts were washed twice with HBSS after treatment. Oocysts washed with sodium hypochlorite and HBSS served as controls. Protease inhibitors and sulfhydryl reagents including hydrogen peroxide (Sigma, St. Louis, Missouri), Nethylmaleimide (NEM, Sigma), dithiolthreitol (DTT, Sigma), ethylenediamine-tetraacetic acid (EDTA), cystatin (Sigma), and phenylmethylsulfonyl fluoride (PMSF, Sigma) were dissolved in phosphate-buffered saline (PBS). PMSF was first dissolved in dimethylsulfoxide (DMSO) and diluted to desired concentrations in PBS. Control assays were prepared in both PBS and DMSO (final concentrations equal to those of diluted PMSF).
Infection was analyzed using Human ileocecal adenocarcinoma cells (HCT-8 cells) (ATCC CCL-244, American Type Culture Collection, Manassas, Virginia), which were maintained in Roswell Park Memorial Institute 1640 medium (Mediatech Cellgro) supplemented with L-glutamine (300 mg/L; Mediatech Cellgro) and N-2-hydroxythylpiperazine-NЈ-2-ethane-sulfonic acid (25 mM; Mediatech Cellgro). For normal cell maintenance medium was supplemented with 5% fetal bovine serum (Biofluids Inc., Rockville, Maryland) and increased to 10% fetal bovine serum for parasite infection . Stock HCT-8 cells were maintained in 75-cm 2 tissue culture flasks in a 5% CO 2 atmosphere at 37 C and 100% humidity and passaged every 3-5 days. Cells were lifted from the surface with a solution of 0.25% (wt/v) trypsin and 0.53 mM EDTA in PBS (Mediatech Cellgro). Trypsinization required 10-to 12-min incubation in the solution at 37 C to assist disruption of the cell monolayer. The cells were collected and pelleted by centrifugation for 10 min at 1,000 g, resuspended in maintenance medium, and split 1: 10. Cell viability was assessed with trypan blue exclusion (0.02% in PBS) and cells counted with a hemacytometer.
For inoculation, HCT-8 cells were seeded on sterile 22-mm 2 glass coverslips in six-well cluster plates (Corning, Corning, New York) at 1 ϫ 10 6 cells per well and grown to ϳ95% confluence in maintenance medium (48 hr). Cryptosporidium parvum oocysts were treated as stated above. For infection of monolayers and before inoculation with oocysts, the maintenance medium was removed and 3 ml growth medium added to each well in six-well cluster plates. Cells were then incubated with treated or nontreated (positive control) oocysts (10 6 oocysts in 1 ml growth medium) for 120 min. After 2 hr, unexcysted oocysts, oocyst walls, and other materials that may have been liberated from the excysted oocysts were removed from the monolayers by washing each inoculated well twice with HBSS. Cells in cluster plates were then placed back in the incubator for 48 hr with 3-4 ml maintenance medium per well.
Parasite infection was assessed 48 hr after infection using an immunohistochemistry stain (Phelps et al., 2001) . Coverslips in six-well cluster plates were fixed with 100% methanol for 20-30 min and washed twice for 5 min each with PBS. Coverslips were removed from cluster plates and processed on slides, first with a rabbit anti-C. parvum primary antibody followed by a biotinylated anti-rabbit secondary antibody and an avidin biotinylated complex (Vectastain ABC Kit, Vector Laboratories, Burlingame, California). Life cycle stages were observed with an immunoperoxidase stain using hydrogen peroxide (Sigma), diaminobenzidine tetrahydrochloride (Sigma), with hematoxylin (Fisher Scientific, Pittsburgh, Pennsylvania) used as a counterstain. Treatment effectiveness was determined by counting the number of positive fields (any field containing a C. parvum life cycle stage) out of 100 total fields observed with ϫ400 magnification. Each individual experiment was performed in triplicate. Percent reduction compared with untreated oocysts was determined using the following equation: ([Control Ϫ Treated]/Control) ϫ 100. Data are expressed as the mean percent inhibition followed by the standard deviation.
Cryptosporidium parvum homogenate was prepared from treated and untreated oocysts as described (Forney et al., 1996a) . Oocysts (10 5 ) suspended in 1 ml of liquid were snap frozen in liquid nitrogen after treatment, then thawed in a 37 C water bath twice, and then sonicated 6 ϫ 1 min in an ice-cooled water bath sonicator to produce the homogenate (Forney et al., 1996a) . The homogenate was used in an assay for protease activity using azocasein (Sigma) as the substrate (Plantner, 1991; Forney et al., 1996a) . Briefly, 2 mg/ml azocasein in 100 mM sodium phosphate buffer was prewarmed to 37 C for 15 min, and 50 l of C. parvum homogenate added, incubated at 37 C for 10-11 hr. After incubation, 40 l of cold 50% trichloroacetic acid (Sigma) was added to each sample to precipitate any undigested azocasein. Samples were incubated on ice for 60 min and then centrifuged at 2,000 g for 10 min. The supernatant was removed to a microtiter plate already containing 200 l of 10 N NaOH in each well. Absorbance was measured at 450 nm with an automated microtiter plate reader (Bio-Tek Instruments, Winooski, Vermont). Diluted trypsin was used as a control, as suggested by Forney et al. (1996a) . Protease activity readings from treated and untreated oocysts were compared and the percent inhibition determined. For excystation, 1 ϫ 10 5 C. parvum oocysts were washed and treated as those used for cell culture infectivity assays described above. Then, oocysts were incubated in 0.75% taurochloric acid (Sigma) for 30 min at 37 C. The excystation solution was observed at ϫ400 and ϫ1,000 magnification using differential interference contrast microscopy (DIC). A total of 100 shells and oocysts was counted. Samples were evaluated in triplicate. Oocysts containing sporozoites were considered unexcysted. Oocysts containing no sporozoite, also called shells, was considered excysted. The extent of excystation was calculated by the Woodmansee method (Woodmansee, 1987; Finch et al., 1993) : excystation ϭ ([oocysts excysted/total oocysts counted] ϫ 100).
Data from individual experiments were considered independent and were performed at least in triplicate. Experiments and controls were analyzed for significant differences using PROC GLM in SAS statistical software (SAS Institute, Cary, North Carolina). Effects of each treatment on parasite viability were considered to be significant when P Ͻ 0.05. Treatments were separated using Tukeys test for significant differences.
HCT-8 cells support complete development of C. parvum and were found to mimic human infection more closely than animal infection assays. The percent inhibition of cell culture infectivity by various treatments was observed and compared with infection with untreated oocysts (Fig. 1) . No developmental life cycle stage was observed after oocysts were treated with any concentration of hydrogen peroxide tested (2 hr, 4 C). Inhibition of in vitro development after treatment of oocysts with EDTA was closest to that caused by hydrogen peroxide, with only a few developing stages observed. EDTA chelates cations (Ca 2ϩ ) and inhibits metalloproteases (Nesterenko et al., 1995) . Hydrogen peroxide may disrupt intracellular calcium levels (Lipton and The average above was obtained from 3 replicate experiments. Treatments with the same symbol were not significantly different from each other (P Ͻ 0.05). Nicotera, 1998), which may result in the reduced infection observed because calcium is necessary for proper cell invasion by C. parvum (Hamer et al., 1994; Upton et al., 1995) . Treatments are significantly different from each other (P Ͻ 0.05), with 2 exceptions: (1) hydrogen peroxide treatments are identical to each other regardless of concentration and (2) inhibition by 1.0 mM DTT and 25 g/ml cystatin was not significantly different (P Ͼ 0.05). DTT reduces sulfhydryls and can inhibit cysteine proteases at relatively high concentrations (5 mM), whereas cystatin is a known cysteine protease inhibitor. Table I shows the percent inhibition resulting from chemical treatment of oocysts. Protease activity was significantly reduced in homogenates prepared from oocysts that were chemically treated compared with those prepared from oocysts treated with HBSS.
Findings in this study, in which oocysts were exposed to protease inhibitors, appear to parallel those in which oocyst homogenates were exposed to inhibitors (Forney et al., 1996a) . Inhibition levels were similar for oocysts treated with 10 mM PMSF, a serine protease inhibitor, and those treated with cysteine protease inhibitors (NEM, DTT, cystatin). Both serine and cysteine proteinases are believed to be associated more with the sporozite outer membrane than with the oocyst membranes (Powers et al., 1993; Okhuysen et al., 1996; Nesterenko et al., 1995) . Exposure to PMSF results in an inhibition of 90.3%, which suggests that some chemicals, such as PMSF, may act within hypochloritepermiabilized oocysts although no statistical difference was observed between oocysts that received the Ͻ5-min pretreatment and those that did not (data not shown). Inhibition by NEM (5.0 mM) and DTT (5.0 mM) were similar, and both treatments affect sulfhydryls and inhibit cysteine protease activity. Inhibition of protease activity by hydrogen peroxide (0.5 and 10 mg/ml) was similar to that by EDTA (1.5 mM). Both chemicals may inhibit sporozoite activity by chelating calcium ions.
Sporozoites did not spontaneously excyst after oocysts were chemically treated before incubation with taurochloric acid at 37 C for 30 min. Table II shows the extent of excystation after oocysts were treated with inhibitory chemicals. The corresponding log reduction was determined from the extent of excystation among control oocysts (89 Ϯ 5.0). Intact oocysts, shells, and sporozoites were observed with DIC microscopy under ϫ1,000 magnification. Sporozoites from oocysts treated with hydrogen peroxide did not show any type of motion, i.e., gliding or flexing, whereas untreated controls were moving. Oxygen radicals generated from the decomposition of hydrogen peroxide may have penetrated the oocyst wall and damaged the pellicle or subcellular organelles of the sporozoites. Sporozoites derived from oocysts treated with inhibitory compounds other than hydrogen peroxide were seen moving and showed no visible physical effect of damage. The extent of excystation among treated oocysts differed significantly from one another, with few exceptions; no difference was found among hydrogen peroxide treatments and 5.0 mM NEM versus 10 mM PMSF did not differ significantly. EDTA (1.5 mM) inhibited excystation by 70%, close to the inhibition by hydrogen peroxide. Exposure of oocysts to EDTA and hydrogen peroxide also significantly reduced or completely inhibited development in cell cultures (Fig. 1) . The cysteine protease inhibitor cystatin did not significantly affect excystation, supporting previous observations (Forney et al., 1996a) .
Results of this study indicate that hydrogen peroxide at these concentrations penetrates or affects the oocyst wall so that sporozoites are rendered nonviable. Concentrations used were chosen on the basis of food additive guidelines and their potential for use in food products without altering the original food flavor (FDA, 2001; Kniel et al., 2003) . After comparison of the inactivation of cell culture infection, protease activity, and excystation with known sulfhydryl-(NEM, DTT, cystatin) and protease (PMSF, EDTA)-reactive agents, the mechanism of action by hydrogen peroxide still is not clear; however, 2 possibilities are suggested, i.e., sulfhydryl oxidation of proteins on the oocyst surface, which may be combined with lipid oxidation, or alteration in the movement of cations. Alternatively, hydrogen peroxide may oxidize cysteine proteases necessary for oocyst wall maintenance thereby reducing wall strength and lessening oocyst viability. Continuing research in this area may seek to provide information on the potential roles of chemical cations and proteases within the mechanisms of oocyst excystation and infection.
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